Advances in the design and therapeutic use of capsaicin receptor TRPV1 agonists and antagonists

This publication has 79 references indexed in Scilit:

• A local route to pain relief
  Nature, 2007
• Developments in the pharmacotherapy of the overactive bladder
  Current Opinion in Urology, 2007
• Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy
  BMC Neurology, 2007
• The TRPV1 receptor and nociception
  Seminars in Cell & Developmental Biology, 2006
• Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo
  Biochemical and Biophysical Research Communications, 2006
• Design of Potent, Orally Available Antagonists of the Transient Receptor Potential Vanilloid 1. Structure−Activity Relationships of 2-Piperazin-1-yl-1H-benzimidazoles
  Journal of Medicinal Chemistry, 2006
• Development of the First Ultra-Potent “Capsaicinoid” Agonist at Transient Receptor Potential Vanilloid Type 1 (TRPV1) Channels and Its Therapeutic Potential
  The Journal of Pharmacology and Experimental Therapeutics, 2005
• Cloning and pharmacological characterization of mouse TRPV1
  Neuroscience Letters, 2004
• The VR1 Antagonist Capsazepine Reverses Mechanical Hyperalgesia in Models of Inflammatory and Neuropathic Pain
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• The influence of local capsaicin treatment on small nerve fibre function and neurovascular control in symptomatic diabetic neuropathy
  Acta Diabetologica, 2002